<![CDATA[Novo Nordisk A/S - Online news Announcements]]><![CDATA[Novo Nordisk tops global list of 100 most sustainable companies]]><![CDATA[FORTUNE'S '100 Best Companies to Work For']]><![CDATA[Novo Nordisk reaches a milestone in animal testing (VIDEO)]]><![CDATA[New partnership launched to tackle diabetes in Qatar]]><![CDATA[Dramatic increase in diabetes prevalence calls for action]]><![CDATA[Novo Nordisk ranked the 22nd Best Multinational Workplace]]><![CDATA[Novo Nordisk to reach 2500 children in India with free insulin and diabetes care (VIDEO)]]><![CDATA[Prestigious film award to documentary on diabetes in Bangladesh (VIDEO)]]><![CDATA[Novo Nordisk marks World Haemophilia Day (VIDEO)]]><![CDATA[Record-high interest for graduate positions in Novo Nordisk (VIDEO)]]><![CDATA[Novo Nordisk submits application to market recombinant treatment for factor XIII deficiency in the US]]><![CDATA[Novo Nordisk launches Annual Report 2010]]><![CDATA[CEOs advocate employee health in Davos]]><![CDATA[Novo Nordisk's new pen for children - NovoPen Echo(R) - wins GOOD DESIGN(TM) Award]]><![CDATA[Novo Nordisk’s innovative needle - NovoTwist® - wins GOOD DESIGN™ Award]]><![CDATA[Diabetes awareness survey reveals alarming figures across the Middle East and Northern Africa regions]]><![CDATA[New training manual for treatment of type 1 diabetes in children in developing countries]]><![CDATA[Novo Nordisk to invest $73m in expansion of manufacturing facility in the US]]><![CDATA[Africa unites on diabetes challenge]]><![CDATA[EFSD, JDRF and Novo Nordisk renew partnership for type 1 diabetes research in Europe]]>